Researchers sought to determine if the CV effect of intensive lifestyle intervention varies depending on if patient’s can maintain weight loss after the initial intervention.
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Investigators sought to determine if an association existed between weight change and major cardiovascular outcomes among patients with type 2 diabetes.
The updated t:connect mobile app is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery via iOS and Android operating systems.
Researchers conducted an indirect treatment comparison of semaglutide 2.0 mg with dulaglutide 3.0 mg or 4.5 mg to observe which was superior in lowering HbA1c and body weight in people with type 2 diabetes.
Investigators evaluated whether maximum body mass index before onset of type 2 diabetes could predict progressive diabetic retinopathy or diabetic nephropathy in patients with type 2 diabetes.
Exercise helps cardiovascular and other physical and clinical outcomes in type 2 diabetes, but the amount and intensity of the exercise needed to make a difference is debated.
Liver, esophageal, endometrial and other cancers are associated with type 2 diabetes and obesity. Researchers studied whether bariatric surgery could reduce these cancer risks.
